胰島β細胞功能測試 — 精準診斷配合精準治療
BChealth — Precise treatment with precise diagnosis
精準辨別糖尿病類型
Classify Your Diabetes Type Precisely
糖尿病的不同類型有著相似的臨床特徵。現時醫生大多用逐步排除法幫助患者分辨所患的糖尿病類型並決定治療方案可惜效率偏低且費時失事，很多時候由於未能正確分類而令患者錯過最合適的治療時機。
通過胰島β細胞功能測試，醫生能精準地把患者的糖尿病分類並決定治療方案。
Different types of diabetes have similar clinical characteristics. At present, doctors mostly use the stepwise elimination method to distinguish the patient's diabetes type and determine a treatment plan. Unfortunately, this method is time-consuming and has low efficiency. Failure to correctly classify the type of diabetes causes many patients to miss the optimal timeframe for treatment.
Doctors can use our test to accurately identify the patient's type of diabetes and decide on treatment options.
您知道嗎？
Do you know?
檢測糖尿病的重要性
The Importance Of Testing Diabetes
根據2大權威糖尿病組織美國糖尿病協會及歐洲糖尿病研究協會共同發表的報告，建議為病人測試C肽及胰島細胞抗體作糖尿病分類¹。國際專家組亦建議以C肽及胰島細胞抗體測試，作爲診斷及管理成年隱匿性自身免疫糖尿病(LADA)的方法²。
對於非糖尿病人士而言，高胰島素抗阻及低β細胞功能會增加患上糖尿病的風險高達5倍。對於已患有糖尿病人士則平均提早至少8年需要使用胰島素³。
According to a jointly published report by two reputable diabetes organizations, the American Diabetes Association and the European Association for Study of Diabetes, it is recommended to test patients for C peptide and islet cell antibodies for diabetes classification.¹ An International Experts Group also recommended C-peptide and islet cell antibody tests as a method for diagnosis and management of latent autoimmune diabetes in adults (LADA)².
For non-diabetes individuals, high insulin resistance and low B-cell function increase the risk of developing diabetes up to 5-fold. For diabetes patient, the time to insulin requirement is at least 8 years earlier on average.³
1.Holt, Richard I. G., et al. “The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).” Diabetologia, vol. 64, no. 12, 2021, pp. 2609–2652., https://doi.org/10.1007/s00125-021-05568-3.
2.Buzzetti, Raffaella, et al. “Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.” Diabetes, vol. 69, no. 10, 2020, pp. 2037–2047., https://doi.org/10.2337/dbi20-0017.
3.Fan B, Wu H, Shi M, Yang A, Lau ESH, Tam CHT, Mao D, Lim CKP, Kong APS, Ma RCW, Chow E, Luk AOY, Chan JCN. Associations of the HOMA2-%B and HOMA2-IR with progression to diabetes and glycaemic deterioration in young and middle-aged Chinese. Diabetes Metab Res Rev. 2022 Jul;38(5):e3525. doi: 10.1002/dmrr.3525. Epub 2022 Mar 8. PMID: 35174618; PMCID: PMC9542522.
← 點擊查看胰島β細胞功能測試小冊子 | View BChealth Leaflet